The fields of couple and family therapy have long and proud traditions of rigorously testing the efficacy of couple-and family-based interventions. Core aspects of these traditions are the use of sound methodological designs and sophisticated statistical analyses for evaluating both statistically significant and clinically significant change. These traditions provide a strong foundation for adapting well-accepted and widely-used methods to the increasingly complex and interdisciplinary clinical challenges being addressed in current couple and family treatment development and evaluation. This chapter begins with a consideration of the evolving context of treatment outcome research in couple and family therapy and presents an integrative conceptual model of relational, psychological, and physical health outcomes that are common targets in current work in couple-and family-based interventions. We then turn to a discussion of current methodological, measurement, and statistical issues in couple-and family-based intervention research and provide recommendations for considering amongst alternatives. We close with recommendations for future methodological development in couple and family therapy research.
time-series analysis (PTSA; Hoeppner, Goodwin, Velicer, & Heltshe, 2007) . PTSA allows for consistency in within-group effects (i.e., changes in outcome variables over time within a couple) to be examined and tested for multiple couples within the sample model while requiring substantially fewer couples to estimate between-group effects than other alternatives like MLM or BSEM. For example, TSPA could be used to examine how a couple-based intervention created changes in relationship distress and depression for each of four couples undergoing treatment and the consistency of the changes observed in relationship distress and depression across the four couples could be tested using PTSA. The combination of these two time-series based techniques create a powerful opportunity for couple therapy researchers to increase the generalizability of small N trials that target one or more outcomes.
Randomized clinical trials (RCTs).
RCTs utilize random assignment to directly compare two or more treatment conditions in order to establish a treatment's generalizability to the target population and understand important between-person's variables. Usually, an experimental treatment is compared with a waitlist control condition (also known as a randomized controlled trial), treatment as usual, or a bona fide treatment that has previously been shown to be efficacious. Evidence for an experimental intervention's efficacy can be provided by establishing superiority to treatment as usual or a waitlist control, or by demonstrating equivalency with an established treatment for the population and outcome of interest. One may also consider the use established outcome norms for common control conditions (e.g., Baucom, Hahlweg, & Kuschel, 2003) in place of an actual control condition.
To minimize the influence of confounding factors such as sample demographics, comorbidities, and treatment adherence on, RCTs historically have exerted high levels of control over study parameters, such as inclusion and exclusion criteria and therapist adherence and competence in delivering treatments. One benefit of doing so is greater ability to test causal hypotheses about a treatment's efficacy by limiting alternative explanations for outcome differences (e.g., by randomly distributing individual characteristics via randomization, excluding factors such as psychosis that may impede ability to participate in and benefit from treatment, or ensuring treatments are delivered as intended). The cost of high levels of control is often that RCTs introduce characteristics of treatments that typically do not occur in non-study settings (e.g., Kazdin, 2008) . For example, RCTs typically have a fixed number of sessions, have more restrictive inclusion and exclusion criteria than community treatment settings, and have greater standardization of treatment through use of manuals and supervision of clinicians.
Participants also typically enter treatment through different avenues than couples entering treatment in the community, and they are more closely monitored than in community settings.
This increased control raises questions about the extent to which results from RCTs generalize to real-world settings. For example, the few trials that have examined couple therapy in real-world settings typically have smaller effect sizes than in RCTs (see Doss et al., 2012) .
Multiphase optimization strategy (MOST) and sequential, multiple assessment, randomized trial (SMART) designs are two recent methodological advancements aimed at addressing concerns about the generalizability of classic RCT designs to the complexities of realworld settings (e.g., Fava, Tomba, & Tossani, 2013) . Whereas RCT designs typically set a predetermined number of sessions and therapists are constrained to a single treatment package, therapists in real-world settings constantly face decision points in therapy that undoubtedly impact outcomes (Collins, Nahum-Shani, & Almirall, 2014) . When faced with early nonresponse, do you stay the course or change direction? What order of interventions is optimal? Understanding these questions is key to optimizing treatment delivery in terms of time, cost, and general resource allocation, yet traditional RCTs are unable to do so. The MOST framework and SMART design use randomization at various time points-in contrast to randomization just at the start as in typical RCTs-to determine the optimal decisions at points over the course of treatment. For example, a SMART modification to Christensen et al.'s (2004) RCT comparing Traditional Behavioral Couple Therapy (TBCT; Jacobson & Margolin, 1979) with Integrative Behavioral Couple Therapy (IBCT; Jacobson & Christensen, 1998) could be to randomly assign half the participants to each condition prior to treatment onset, as they did, then halfway through treatment randomly assign half the non-responders in each treatment to the alternative condition and half to continued treatment in that condition. This modification would allow a test of whether nonresponders in one treatment would respond better to the other treatment.
As couple-based interventions continue to expand in scope and to be used to treat a broader range of psychological and physical illnesses, a key question will be determination of how to integrate these couple-based interventions with existing treatment options to maximize the efficiency and flexibility of treatment regimens. Such treatments will likely involve multidisciplinary collaboration with several treatment providers. For example, a recently developed couple-based intervention for Anorexia Nervosa involved a treatment team of psychiatrists, nutritionists, and couple therapists (Bulik et al., 2011) . Some couple-based interventions may become a first line treatment for a disorder, others may be one of a set of equivalently efficacious treatment options for a disorder, and still others may become an adjunctive treatment that is indicated for cases that fail to improve after a course of individual and/or pharmacotherapy or that can be used to enhance treatment gains after initial treatment with some other form of intervention. MOST and SMART designs hold great promise for testing amongst these various possibilities. (Schnurr, 2015) . Veterans with PTSD are not actively recruited for the study; rather, veterans who are already seeking treatment for PTSD are provided the option to enroll in the study, and those who agree are then randomized to one of the two treatments. Often, experimental treatments are first tested using the more controlled RCT design to establish efficacy under optimal conditions, and then later, once evidence of efficacy has been established, tested using effectiveness designs to examine the treatment in settings closer to realworld treatment settings. Therefore, an effectiveness trial can be seen as a "bridge" between research and practice settings (Baker, McFall, & Shoham, 2008) . Although they are often discussed separately, RCTs and effectiveness trials do not represent a dichotomy, but instead describe a continuum (Baker et al., 2008) , and where a study falls on the continuum depends on the extent to which it prioritizes internal validity (closer to efficacy) or external validity (closer to effectiveness). However, Christensen et al. (2005) argue convincingly that it is possible to optimize both internal and external validity in clinical trials and that the two are not mutually exclusive.
Large-scale effectiveness trials have been rare in the field of couple therapy. One possibility for why there have been so few published effectiveness trials is that there have historically been few large-scale treatment providers who offer couple-based interventions. The Veterans Administration (VA) is one exception to this general trend in that it is both one of the largest providers of psychological treatment in the United States and that it offers an expanding range of couple-based interventions. Indeed, the largest effectiveness trial of couple therapy of which we are aware was conducted in the VA (Doss et al., 2012) . Additional effectiveness research is clearly one of the pressing needs for future couple therapy research.
Selecting and Assessing Outcome Variables
In addition to selecting the study design, determining which constructs will be assessed as primary and secondary outcomes and what methods will be used to measure those constructs is another crucial decision in efficacy research. As is true of construct measurement in general, there are numerous methods for assessing most constructs and the choice of which particular construct is measured and the method of measuring it are influenced by numerous factors including the theoretical model of dysfunction guiding the study, study design, and available resources. Selection of constructs and methods of measurement is also invariably influenced by a research team's areas of expertise. Self-report measures of a wide range of relationship and individual functioning constructs and observational assessment of communication behavior and affective expression are widely represented in couple therapy efficacy research and are methods that are likely to be familiar for many couple therapy researchers (see Chapter 3 by Snyder, this volume). Psychophysiological outcomes are extremely rare in couple therapy research and are likely to be less familiar for couple therapy researchers, perhaps indicating less familiarity with these methods than with self-report and observational coding. We therefore begin by presenting a model of both the conceptual points of overlap and the uniquenesses for these three methods, followed by a brief overview of self-report and observational coding methods and closing with a more in-depth discussion of a conceptual model for integrating psychophysiological outcomes into future couple therapy research.
Conceptual model of self-report, observational coding, and psychophysiological measures. Figure 2 presents a Venn diagram representation of the common methods of measurement for constructs of frequent interest in couple therapy outcome research and how they relate to internal and outwardly observable processes. This conceptual model is an adaptation of Scherer's (2009) highly influential component process model of emotion (CPME).
Many of the ideas of the CPME are relevant for constructs commonly represented in couple therapy research, with minor adaptation. In this model, a distinction is drawn between internal processes that are generally not outwardly observable and behavior that is outwardly observable.
Internal processes are further divided into unconscious or automatic internal processes (e.g., physiological reactivity during a conflictual conversation with a romantic partner) and conscious or effortful internal processes (e.g., trying to understand a romantic partner's perspective during a conflictual conversation). The model also suggests that self-report measures assess the point of overlap between internal processes and observable behavior. This suggestion makes a strong assumption about the nature of self-report measures, namely that they are representative of internal processes that the respondent is both aware and unaware of, and that some of what respondents report is to a certain extent observable to others. Another assumption about selfreport as shown by this diagram is that it has unique explanatory value not captured by observational coding or physiology. The reverse is also true, that some of the observable behaviors captured by coding and some of the unconscious or automatic internal processes captured by physiology are not captured by self-report.
---Insert Figure 2 about here ---Self-report measures. Owing to the ease of delivery and the conceptual benefit of directly measuring an individual's experience, self-report measurement is perhaps the most frequently used method for measuring primary outcomes in psychological intervention research in general. Self-report measures of primary outcomes are also widely used in couple intervention research largely because of the central role of relationship satisfaction as a primary outcome measure. Other constructs commonly measured via self-report include relationship stability (e.g., Weiss & Cerreto, 1980) , communication (e.g., Crenshaw, Christensen, Baucom, Epstein, & Baucom, in press), aggression (e.g., Straus, Hamby, Boney-McCoy, & Sugarman, 1996) , process measures such as therapeutic alliance, and individual functioning variables.
Self-report measurement will likely remain a mainstay method for measuring primary outcome targets. As couple therapy research continues to expand in scope, it will be important for treatment researchers to be mindful of issues that have arisen in other treatment outcome literatures that are likely to arise with greater frequency in the couple therapy literature as primary outcome targets move further afield from relationship satisfaction. One problem that is likely to have increasing relevance for couple therapy researchers is that multiple primary outcome measures assessed via self-report often do not agree with one another in speaking to a treatment's efficacy or that two treatments may appear equivalent in one domain but not in The concept of enduring vulnerabilities in psychophysiological research is both similar to and different from the application of the same concept to self-reported traits or previous life experiences. The similarity is the conceptual notion of individual differences, namely that individuals can be rank ordered according to the value of some physiological or self-reported metric. The difference is in the interpretability of the rank ordering. Self-report measures are designed to be scaled such that if one participant has a higher score than another, that participant possesses a higher level of the trait being measured than does the other.
1 It is much more difficult, and at times impossible, to interpret individual differences in resting physiology in the same manner. At one extreme, individual differences in resting electrodermal activity (EDA; also known as galvanic skin response [GSR] and skin conductance) are influenced by such a wide array of factors that they are generally understood to be uninterpretable. In contrast, individual differences in resting respiratory sinus arrhythmia (RSA) are well-accepted to be an index of Self-report measures that perform in this manner are said to be factorially invariant, meaning that the factor structure of the scale is known to be equivalent for all groups of respondents. Very few self-report measures used in relationship science have been subjected to factorial invariance testing and are presumed, but not known, to be at least weakly factorially invariant. See South, Krueger, and Iacono (2009) for an example application of factorial invariance to the Dyadic Adjustment Scale (Spanier, 1976) and Meredith (1993) for additional discussion of factorial invariance Brown & Smith, 1992] ). Because of the range of factors influencing physiological reactivity, current interpretive recommendations encourage a focus on the physiological system involved and careful, if not tentative, interpretation of psychological meaning (Cacioppo & Tassinary, 1990 ). For example, much less is known about the psychological constructs involved in taskrelated changes in RSA compared to individual differences in resting RSA. However, changes in RSA are known to be strongly related to changes in parasympathetic activity (i.e., the "rest and Finally, surrogate and clinical endpoints refer to biological indices that are associated with risk factors for or pre-cursors of (surrogate endpoints), clinical indications of (clinical endpoints), or formal diagnosis of (clinical endpoints) physical illness. For example, stress, heightened systolic blood pressure, and obesity are all risk factors for cardiovascular disease (e.g., Kannel, Gordon, & Schwartz, 1971; Van Gaal, Mertens, & Christophe, 2006) . In the conceptual model advanced in this chapter, stress corresponds to the stress variable on the left side of Figure 1 , blood pressure reactivity during couple conflict would represent a biological adaptive response to the stressor, obesity would be a surrogate endpoint, and a diagnosis of coronary heart disease would be a clinical endpoint (e.g., Smith & Ruiz, 2002) . Though an oversimplification, one practical guideline for understanding where a given physiological measure would fall in Figure 1 is that physiology measures obtained during most tasks individual-level variables that are measured once during the study (e.g., personality) are entered at Level 2, and couple-level variables that are measured once during the study (e.g., family income) are entered at Level 3. The structure of MLM allows higher level variables to predict either the intercept of the lower level, constituting a main effect for that higher level variable, or any lower-level slope, constituting an interaction (also known as a cross-level interaction). If one wants to examine whether change over time occurs nonlinearly (e.g., quadratic), one can add Time 2 as a predictor at level 1. 2 To examine a main effect of treatment condition at the start of the study, it is entered at the couple level (L3) on the intercept (line 4, β00k = γ000 + γ001 * Treatment condition +µ00k). To examine the impact of a personality characteristic on outcome at the start of the study (e.g., neuroticism), it is entered at L2 on the intercept (line 2, π0jk = β00k + β01k* Neuroticism + r0jk). To examine the impact of a time-varying variable (e.g., depressive symptoms) on the outcome, it is entered as a predictor at L1 ( (2014) provide an excellent and accessible tutorial on implementing these models, which can be used to estimate using most MLM statistical packages.
Methods of Estimating Effect Sizes in MLMs
One complication of using MLMs to quantify the magnitude of change over time is that it is commonly desirable to present such estimates in effect size metric, but there currently is no agreed upon method for estimating effect sizes in MLMs. Methods for estimating effect sizes in
MLMs is an area of ongoing research, and currently available methods are best considered to be reasonable approximations of effect sizes. Current methods generate these estimates for the 
Methods for Determining Clinically Significant Change
The statistical significance of change created by a couple therapy tests whether a grouplevel change in the outcome variable is greater than chance, but it does not convey information about whether those differences are meaningful to the individuals undergoing treatment. The latter is referred to as clinical significance, and it is now a staple of clinical intervention research and used to supplement statistical significance. Additionally, clinical significance may point to a treatment's efficacy in case studies or small-N trials, when examining between-group differences statistically is unadvisable because of insufficient power. Two criteria in determining whether a given client achieved clinically significant change is that they show reliable improvement on measure(s) of interest (i.e., changed an amount greater than measurement error) and they surpass a predefined cutoff such that they are statistically indistinguishable from nondistressed individuals (see Lambert & Ogles, 2009 , for a thorough discussion and history of clinical significance). The original method proposed by Jacobson, Follette, and Revenstorf (1984) established four categories that participants may fall into: recovered (reliable improvement and passed the predetermined cutoff), improved (reliable improvement but did not pass the cutoff), unchanged (neither criteria met), or deteriorated (reliable decline; McGlinchey et al., 2002 ). An advantage of including clinical significance in clinical trials is that, in addition to examining mean-level treatment differences via statistical significance, one can also examine whether two treatments produce different clinically-meaningful outcomes. 
